Tag: FDA
How to alleviate ravages of the disease without bankrupting individuals or Medicare program? The Food and Drug Administration recently granted fast-track approval to a new Alzheimer’s drug designed to slow the rate of cognitive decline for individuals in the early stages of the disease. The drug, which will be sold under the brand name Leqembi,…